Acadia Pharmaceuticals Inc (ACAD):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Acadia Pharmaceuticals Inc (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C10071)・商品コード:DATA904C10071
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:44
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Acadia Pharmaceuticals Inc (Acadia) discovers, develops and commercializes small molecule drugs for the treatment of central nervous system disorders. The company’s lead product Nuplazid (pimavanserin) is an FDA approved drug for the treatment of Parkinson’s disease psychosis. Acadia also develops pimavanserin for the treatment of Alzheimer’s disease agitation and Alzheimer’s disease psychosis and as an adjunctive treatment for schizophrenia and major depressive disorder (MDD). The company has partnerships for the development of its drug candidates in the therapeutic areas of pain and ophthalmology. It has operational presence in Denmark and Switzerland. Acadia is headquartered in San Diego, California, the US.

Acadia Pharmaceuticals Inc (ACAD) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
ACADIA Pharma Enters into Licensing Agreement with Neuren Pharma 10
Equity Offering 11
Acadia Pharma Completes Underwriter’s Exercise of Over-Allotment Option of Public Offering for USD230 Million 11
Acadia Pharma Raises USD300 Million in Public Offering of Shares 13
Acadia Pharma Raises USD209.8 Million in Public Offering of Shares 15
Acadia Pharma Completes Public Offering Of Shares For US$115 Million 17
Acadia Pharma Completes Private Placement Of Shares And Warrants For US$84 Million 19
Acadia Pharmaceuticals Inc – Key Competitors 20
Acadia Pharmaceuticals Inc – Key Employees 21
Acadia Pharmaceuticals Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Nov 07, 2018: ACADIA Pharmaceuticals reports third quarter 2018 financial results 23
Aug 08, 2018: ACADIA Pharmaceuticals reports second quarter 2018 financial results 25
May 04, 2018: ACADIA Pharmaceuticals Announces First Quarter 2018 Financial Results 27
Feb 27, 2018: ACADIA Pharmaceuticals Announces Fourth Quarter and Full Year 2017 Financial Results 29
Nov 07, 2017: ACADIA Pharmaceuticals Reports Third Quarter 2017 Financial Results 31
Aug 08, 2017: ACADIA Pharmaceuticals Reports Second Quarter 2017 Financial Results 33
May 09, 2017: ACADIA Pharmaceuticals Reports First Quarter 2017 Financial Results 35
Feb 28, 2017: ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016 37
Corporate Communications 39
Sep 26, 2018: ACADIA Pharmaceuticals announces executive appointments 39
May 02, 2018: ACADIA Pharmaceuticals Announces Appointment of Elena Ridloff, CFA, as Senior Vice President, Investor Relations 40
Dec 13, 2017: ACADIA Pharmaceuticals Announces Appointment of Damien McDevitt, Ph.D., as Senior Vice President, Corporate Development 41
Mar 30, 2017: ACADIA Pharmaceuticals Announces Appointment of Michael J. Yang as Executive Vice President, Chief Commercial Officer 42
Legal and Regulatory 43
Jul 25, 2018: Federman & Sherwood announces filing of securities class action lawsuit against Acadia Pharmaceuticals 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Acadia Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ACADIA Pharma Enters into Licensing Agreement with Neuren Pharma 10
Acadia Pharma Completes Underwriter’s Exercise of Over-Allotment Option of Public Offering for USD230 Million 11
Acadia Pharma Raises USD300 Million in Public Offering of Shares 13
Acadia Pharma Raises USD209.8 Million in Public Offering of Shares 15
Acadia Pharma Completes Public Offering Of Shares For US$115 Million 17
Acadia Pharma Completes Private Placement Of Shares And Warrants For US$84 Million 19
Acadia Pharmaceuticals Inc, Key Competitors 20
Acadia Pharmaceuticals Inc, Key Employees 21
Acadia Pharmaceuticals Inc, Other Locations 22
Acadia Pharmaceuticals Inc, Subsidiaries 22

List of Figures
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★調査レポート[Acadia Pharmaceuticals Inc (ACAD):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C10071)販売に関する免責事項を必ずご確認ください。
★調査レポート[Acadia Pharmaceuticals Inc (ACAD):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆